Correlation Between ImmunoCellular Therapeutics and Novo Nordisk
Can any of the company-specific risk be diversified away by investing in both ImmunoCellular Therapeutics and Novo Nordisk at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining ImmunoCellular Therapeutics and Novo Nordisk into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between ImmunoCellular Therapeutics and Novo Nordisk AS, you can compare the effects of market volatilities on ImmunoCellular Therapeutics and Novo Nordisk and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in ImmunoCellular Therapeutics with a short position of Novo Nordisk. Check out your portfolio center. Please also check ongoing floating volatility patterns of ImmunoCellular Therapeutics and Novo Nordisk.
Diversification Opportunities for ImmunoCellular Therapeutics and Novo Nordisk
0.0 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between ImmunoCellular and Novo is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding ImmunoCellular Therapeutics and Novo Nordisk AS in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Novo Nordisk AS and ImmunoCellular Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on ImmunoCellular Therapeutics are associated (or correlated) with Novo Nordisk. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Novo Nordisk AS has no effect on the direction of ImmunoCellular Therapeutics i.e., ImmunoCellular Therapeutics and Novo Nordisk go up and down completely randomly.
Pair Corralation between ImmunoCellular Therapeutics and Novo Nordisk
If you would invest 8,519 in Novo Nordisk AS on November 29, 2024 and sell it today you would earn a total of 436.00 from holding Novo Nordisk AS or generate 5.12% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Flat |
| Strength | Insignificant |
| Accuracy | 0.0% |
| Values | Daily Returns |
ImmunoCellular Therapeutics vs. Novo Nordisk AS
Performance |
| Timeline |
| ImmunoCellular Therapeutics |
Risk-Adjusted Performance
Very Weak
Weak | Strong |
| Novo Nordisk AS |
ImmunoCellular Therapeutics and Novo Nordisk Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with ImmunoCellular Therapeutics and Novo Nordisk
The main advantage of trading using opposite ImmunoCellular Therapeutics and Novo Nordisk positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if ImmunoCellular Therapeutics position performs unexpectedly, Novo Nordisk can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Novo Nordisk will offset losses from the drop in Novo Nordisk's long position.The idea behind ImmunoCellular Therapeutics and Novo Nordisk AS pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
| Novo Nordisk vs. Regeneron Pharmaceuticals | Novo Nordisk vs. Crispr Therapeutics AG | Novo Nordisk vs. Sarepta Therapeutics | Novo Nordisk vs. Intellia Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.
Other Complementary Tools
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities |